🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07788859
Recruiting Observational

Reliability and Validity of Three DT-TUG Protocols in MS

NCT07788859 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2026-03-16
Last updated
2026-08-27

Condition(s) studied

Multiple Sclerosis

Investigational drug(s) / intervention(s)

Intra-rater reliability analysisInter-rater reliability analysisConvergent validity

Intra-rater reliability analysis: For the intra-rater reliability analysis, three DTUG protocols will be evaluated at 7- to 10-day intervals.

Inter-rater reliability analysis: For the inter-rater reliability analysis, three DTUG protocols will be administered to the same patient by two different physical therapists.

Convergent validity: To assess convergent validity, the relationship between the measurements from the three DTUG protocols and the results of other balance and functional mobility tests will be examined.

Study summary

Dual-tasking is performing two different tasks at the same time. For example, singing while cooking. Everyday activities often involve dual-task. In many researches evaluating dual-task performance in individuals with MS, it has been reported that individuals with severe disability, in particular, exhibit greater effort than healthy individuals. This increase in motor and cognitive dual-task performance in individuals with Multiple Sclerosis (MS) is associated with an increased risk of falls. There is a need for standardized, valid, and reliable assessment tools to evaluate dual-task performance in MS. The purpose of this study is to examine and compare the validity and reliability of the dual-task Timed Up and Go test administered using three different protocols.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Having been diagnosed with MS according to the McDonald criteria revised in 2017, * Being between the ages of 18 and 65, * Having an Expanded Disability Status Scale (EDSS) score between 0 and 5.5, * Not requiring any assistive walking devices. Exclusion Criteria: * Pregnancy; * Having experienced a relapse within the past three months; * The presence of another neurological condition in addition to MS; * The presence of a different disorder that could potentially affect gait parameters; * The presence of visual, auditory, perceptual, or cognitive impairments severe enough to interfere with the test administration

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
SANKO University Gaziantep Turkey (Türkiye) Recruiting

More Afyonkarahisar Health Sciences University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07788859 on ClinicalTrials.gov ↗ ← All trials in Turkey